Aroylhydrazones 1-13 were screened for antimicrobial and antibiofilm activities in vitro. N'-(2-hydroxy-phenyl methylidene)-3-pyridinecarbohydrazide (2), N'-(5-chloro-2-hydro xyphenyl-methylidene)-3-pyridinecarbohydrazide (10), N'-(3,5-chloro-2-hydroxyphenylmethylidene)-3-pyridinecarbohydrazide (11), and N'-(2-hydroxy-5-nitrophenyl methyl idene)-3-pyridinecarbohydrazide (12) showed antibacterial activity against Escherichia coli, with MIC values (in µmol mL ). Good activity regarding multi-resistant clinical strains was observed for compound 12 against MRSA strain (MIC 0.02 µmol mL ). Anti-biofilm activity was found for compounds 2 (MBFIC 0.015-0.02 µmol mL -1 against MRSA) and 12 (MBFIC 0.013 µmol mL -1 against EBSL+ E. coli). In the case of compound 2 against MRSA biofilm formation, MBFIC values were comparable to those of gentamicin sulphate, whereas in the case of compound 12 and EBSL+ E. coli even more favourable activity compared to gentamicin was observed.
Antimicrobial assesment of aroylhydrazone derivatives in vitro
Aroylhydrazones 1-13 were screened for antimicrobial and antibiofilm activities in vitro. N'-(2-hydroxy-phenyl methylidene)-3-pyridinecarbohydrazide (2) , N'-(5-chloro-2-hydro xyphenyl-methylidene)-3-pyridinecarbohydrazide (10) , N'-(3,5-chloro-2-hydroxyphenylmethylidene)-3-pyridinecarbohydrazide (11) , and N'-(2-hydroxy-5-nitrophenyl methyl idene)-3-pyridinecarbohydrazide (12) showed antibacterial activity against Escherichia coli, with MIC values (in µmol mL ). Good activity regarding multi-resistant clinical strains was observed for compound 12 against MRSA strain (MIC 0.02 µmol mL -1 ) and compounds 2, 6 and 12 against ESBL+ E. coli MFBF 12794, with the lowest MIC for compound 12 (IC 50 0.16 µmol mL -1 ). Anti-biofilm activity was found for compounds 2 (MBFIC 0.015-0.02 µmol mL -1 against MRSA) and 12 (MBFIC 0.013 µmol mL -1 against EBSL+ E. coli). In the case of compound 2 against MRSA biofilm formation, MBFIC values were comparable to those of gentamicin sulphate, whereas in the case of compound 12 and EBSL+ E. coli even more favourable activity compared to gentamicin was observed.
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Aroylhydrazones contain an azomethine group -NHN=CH-connected with carbonyl group, which is responsible for their different pharmaceutical applications. Therefore, aroylhydrazones have attracted considerable attention for their wide range of biological
activities, such as antimicrobial, anticonvulsant, antitumor, analgesic, antiplatelet, antitubercular and anti-inflammatory activities (1, 2) . Further, hydrazones as chelating agents were investigated as potential drugs for the treatment of a disease called "iron overload disease" (3) . Salicylaldehyde derivatives were shown to be selective iron chelators with promising pharmacological properties (4). However, pharmacokinetic studies have stressed the relatively short biological half-life of certain hydrazones due to hydrolysis of the hydrazone bond, which is typical for this class of compounds (4, 5) . Molecular structural changes of aroylhydrazones derived from salicylaldehyde, o-vanilin and nicotinic acid hydrazide in dimethylsulphoxide/water (DMSO/water) mixtures were studied by NMR, UV-Vis, ATR and Raman spectroscopy (6) . Results obtained by Galić et al. (6) revealed that addition of water to the system did not induce tautomeric conversion of the ketoamino hydrazide part and the enolimino aldehyde part. Furthermore, addition of water showed formation of hydrated molecules and compounds were quite stable in DMSO/ water mixtures (V(DMSO)/V(H 2 O), of 9/1, 8/2, 7/3 and 6/4 volume ratios).
According to the work done by Da Costa et al. (7) , in vitro evaluated N-acylhydrazone derivatives of different amino acids such as l-phenylalanine, l-leucine and l-alanine against M. tuberculosis showed a MIC between 12.5-50 µg mL Benzimidazole derivatives bearing hydrazone moiety revealed that some of the compounds had a bactericidal effect on the growth of Salmonella typhimurium, two times better or equal to the activity of chloramphenicol, which was used as a positive control (9) . Activities of these compounds against other Gram-negative bacterial strains such as Escherichia coli, Proteus vulgaris, Klebsiella pneumoniae or Pseudomonas aeruginosa were good, with the MIC value of 25-100 µg mL -1
. Activities against Gram-positive bacteria were determined on four strains: Listeria monocytogenes, Staphylococcus aureus, Enterococcus faecalis and Bacillus subtilis. The best activity, equal to the activity of chloramphenicol, was found against an E. faecalis strain with the MIC value of 12.5 µg mL As a part of our investigations on aromatic hydrazones derived from nicotinic acid hydrazide (10), a group of 13 derivatives ( Fig. 1 ) was studied for antimicrobial activity in the present work. Our research was focused on antibacterial, antifungal and antibiofilm studies in vitro.
EXPERIMENTAL

Chemicals
Chemicals used in this study, such as acetic acid glacial (Panreac, Spain), dimethyl sulfoxide pure (Lach-Ner, Czech Republic), methanol (Merck KgaA, Germany), are commercially available and were used without further purification, while aroylhydrazone derivatives were synthesized by previously described procedures (11) and analyzed using standard analytical methods. Drugs used as positive controls were gentamicin sulphate and colistin purchased from Sigma-Aldrich, nystatin from PLIVA Hrvatska (Croatia), norfloxacin from Krka-Farma (Slovenia) and voriconazole from Pfizer (USA). 
Microorganisms and media
Antimicrobial susceptibility testing
Minimum inhibitory concentrations (MICs) were measured by the serial two-fold microdilution broth assay in Mueller-Hinton broth for bacterial strains, and RPMI with 2 % of glucose broth for fungi according to the recommendations of EUCAST protocols (12, 13) .
Compounds 1-13 were first dissolved in DMSO/water (1:1, V/V), followed by dilution with sterile physiological saline to a stock concentration of 800 µg mL
. The solvent mixture was tested as a negative control in all assays.
Inoculum suspensions of bacteria and fungi were prepared from fresh cultures of microbial strains cultured on the surface of tryptic-soy agar for 18 h at 35 °C for bacterial species, and on Sabouraud 2 % (m/V) glucose agar for 48 h at 35 °C for yeast and fungi. Inocula were prepared with physiological saline and cell density was adjusted to 0. . Serial two-fold microdilution . After inoculation and aerobic incubation for 18 h at 35 °C in the dark, MICs of bacterial strains were determined by adding the redox-indicator 2,3,5-triphenyl-2H-tetrazolium chloride [TTC, 1.0 % (m/V), in sterile physiological saline]. After 3 hours of incubation at 35 °C in the dark, 0.04 mol L -1 HCl in isopropanol was added to all wells and absorbance was recorded at 540 nm using a microtiter plate reader (Labsystems iEMS Reader MF, Finland). MIC was defined as the lowest concentration of investigated compounds that inhibited 90 % of the growth compared to the negative control; values for 50 % growth inhibition are shown as well. MICs for C. albicans strains were obtained by determing absorbance at 540 nm using the above mentioned microtiter plate reader. MIC values for mold A. brasiliensis ATCC 16404 were determined visually after 48 h of incubation, aerobically at 35 °C in the dark. MICs were calculated using the Gompertz non-linear regression model, evaluating the % microbial viability vs. log conc (GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla California USA, www.graphpad.com) to get the final IC 90 and IC 50 values expressed in mg mL . All tests were performed in triplicate and results are expressed as the mean value. Minimal inhibitory concentrations are shown in Table I .
Determination of anti-biofilm activity
Compounds that showed antimicrobial activity against the tested clinical microbial strains MRSA MFBF 10679, ESBL+ E. coli MFBF 12794 and Ca FLR+ MFBF 11103 were investigated for anti-biofilm activity using the crystal violet assay according to Vlainić et al. (14) with slight modifications. The effect on biofilm formation was evaluated by determining the minimum biofilm formation inhibition concentration (MBFIC). Inoculum suspensions of fresh cultures of microbial strains were prepared with sterile physiological saline and cell density was adjusted to 0. . Experiments were performed in sterile 96-well flat-bottom plastic tissue plates (TPP, Switzerland). Investigated compounds were tested in the concentration range from 500 to 3.91 µg mL -1
. Untreated controls contained inoculum in broth, and standard antimicrobial drugs were used for positive controls -gentamicin sulphate (stock concentration used for ESBL+ E. coli MFBF 12794 was 1 mg mL -1 , while stock concentration for MRSA MFBF 10679 was 600 µg mL ) for bacteria, nystatin and voriconazole (stock concentration of 400 µg mL -1 each) for fungi. Only broth was used for negative controls. After a 24-h incubation period for bacteria and 48 h of incubation for yeast (37 °C, aerobic, in the dark), wells were aspirated and washed four times with 250 µL of PBS and shaken vigorously. Adherent microbial cells were treated with methanol for 20 min and left to dry overnight. The formed biofilm was stained with crystal violet (0.5 %, m/V, in methanol) for 10 min. Residual crystal violet was aspirated and plates were rinsed with tap water and left to dry overnight. Adherent biofilm was resolubilized with glacial acetic acid. Results were obtained by measuring absorbance at 540 nm using a microtiter plate reader (Labsystems iEMS Reader MF). The MBFIC 50 and MBFIC 90 values represent the lowest compound dilutions at which microbial growth during biofilm formation was inhibited by 50 and 90 %, resp., compared to the untreated control (inoculum with broth). MBFICs were calculated from linear regression of the log of concentration of compounds vs. % reduction, using the GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla California USA, www.graphpad.com. All tests were performed in triplicate and the results are expressed as the mean value.
RESULTS AND DISCUSSION
All the compounds 1-13 were screened for their in vitro antibacterial activity against S. aureus (Gram-positive) and E. coli (Gram-negative) strains, C. albicans (yeast) and A. brasiliensis (filamentous fungus).
Susceptibility of the tested microbial species to aroylhydrazone compounds showed species-dependent and compound-dependent activity. Pronounced activities were detected for compounds 2, 6, 7, 8, 10, 11, 12 and 13. Compounds 2, 6, 7, 11 and 12 showed good activity against multi-resistant clinical strains MRSA, ESBL+ E. coli and C. a.
FLR+
, still lower than that of reference drugs. The same applies to compounds 11 and 12, which were highly active against S. aureus ATCC 6538 (both 11 and 12), C. albicans ATCC 10231 (11) and E. coli ATCC 10536 (11) . In all of these cases, MIC values were markedly higher than for standard drugs. Good activity against both investigated C. albicans strains was shown by compound 11. The lowest MIC value of 4.0 ´ 10 -2 µmol mL -1 against C. albicans ATCC 10231 was fairly comparable with the lowest MIC value of nystatin of 1.7 ´ 10 -2 µmol mL -1
. Compound 7 showed somewhat lower activity against both C. albicans strains with higher MIC values (IC 90 range 0.18-0.10 µmol mL -1 ). Only compound 12 showed good activity against the MRSA strain, but still markedly lower than gentamicin sulphate. Compounds 2, 6 and 12 showed activity against ESBL+ E. coli MFBF 12794, with the lowest MIC in the case of compound 12 (IC 50 0.16 µmol mL ).
None of the tested compounds showed a wide spectrum of antibacterial activity against multi-resistant clinical strains and none of the compounds showed activity against A. brasiliensis in the concentration range tested.
Antibacterial tests performed in this study showed that compounds 10 and 11, bearing one and two chloro atoms, resp., as well as compound 12 with a nitro group, showed good inhibition of bacterial growth whereas the compounds without an electron withdrawing group (chloro-and nitro-) showed weak antimicrobial activity. This may be due to the fact that electron withdrawing substituents (chloro-, nitro-) increase the lipophilicity of the compounds, which leads to higher partitioning of such compounds into the lipophilic phase of a microbial membrane. This causes higher local concentration of the compound near a biological target site (1) . Furthermore, hydrazones with a strong electron withdrawing substituent (fluorine) showed high bioactivity and were commonly used in medicine to improve metabolic stability, bioavailability and protein ligand interactions (15) .
According to the experimental results, none of the compounds under investigation showed anti-biofilm activity of C. a.
FLR+ at the tested concentrations. As shown in Table II , anti-biofilm activity of compounds 2 and 12 was detected in the case of MRSA and EBSL + E. coli. Compound 2 showed good activity only against the formation of biofilm formed by MRSA, while compound 12 showed good activity only against the formation of biofilm formed by EBSL + E. coli. In the case of compound 2 against MRSA biofilm formation, MBFIC values (1.5 ´ 10 -2 µmol mL ), whereas in the case of compound 12 and EBSL+ E. coli even more favourable activity versus gentamicin was recorded. Results reveal that the type of substituent in the molecule that determines hydrophobicity/hydrophilicity of the hydrazone could be affecting quorum sensing systems (QS) involved in anti-biofilm activity and, therefore, in future, further investigation of this issue should be performed.
Compounds containing electron withdrawing groups generally exert better antimicrobial activity against Gram-negative bacteria. These findings can be explained by the differences between Gram-negative and Gram-positive bacteria. Gram-negative bacteria are surrounded by a thin peptidoglycan cell wall, which itself is surrounded by an outer membrane containing lipopolysaccharide. Gram-positive bacteria lack an outer membrane but are surrounded by layers of peptidoglycan many times thicker than those found in Gram-negative bacteria. Nitro group is a strong electron-withdrawing group, situated in para position to a hydroxyl group in compound 12, which leads to increased lipophilicity. Increased lipophilicity promotes entrance of substances into the cell membrane and causes structural defects leading to cell death. As already mentioned, compound 12 (nitro substituted) showed high activity against the formation of a biofilm formed by the Gram-negative bacterium (EBSL+ E. coli).
CONCLUSIONS
All the title compounds were screened for their in vitro antimicrobial activity against S. aureus (Gram-positive bacterium), E. coli (Gram-negative bacterium), C. albicans and A. Compounds 2, 6, 10, 11 and 12, which showed good antimicrobial activity, were also investigated on multi-resistant clinical strains MRSA, ESBL+ E. coli and C. a.
FLR+
. Experimental results showed that only compounds 2 and 12 showed good activity against biofilm formation. Compound 2 showed good activity against formation of the biofilm formed by MRSA, while compound 12 showed only good activity against formation of the biofilm formed by EBSL + E. coli. In the case of compound 2 against MRSA biofilm formation, MBFIC values were comparable to those of gentamicin sulphate, whereas in the case of compound 12 and EBSL+ E. coli even more favourable activity compared to gentamicin was observed.
